Correspondence 0001104659-23-006263 from Journey Medical Corp (DERM)

Journey Medical Corp
Date: Jan. 24, 2023 · CIK: 0001867066 · Accession: 0001104659-23-006263

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-269079

Date

January 24, 2023

Author

/s/ Claude Maraoui

Form

CORRESP

Company

Journey Medical Corp

Letter

Re: Journey Medical Corporation

January 24, 2023

VIA EDGAR

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-3

File No. 333-269079

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Journey Medical Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 4:30 p.m. Eastern time, on January 26, 2023, or at such other time as the Company or its outside counsel, McGuireWoods LLP, may request via a telephone call to the staff of the Commission.

Once the Registration Statement has been declared effective, please orally confirm that event with Rakesh Gopalan of McGuireWoods LLP at (704) 343-2275, or in his absence, David Wolpa of McGuireWoods at (704) 343-2185.

Thank you for your assistance in this matter.

Very truly yours,
/s/ Claude Maraoui

Show Raw Text

CORRESP
1
filename1.htm

January 24, 2023

VIA EDGAR

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Journey Medical Corporation

    Registration Statement on Form S-3

    File No. 333-269079

Ladies and Gentlemen:

Pursuant to Rule 461
under the Securities Act of 1933, as amended, Journey Medical Corporation (the “Company”) hereby requests that the
Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration
Statement on Form S-3 (the “Registration Statement”) so that the Registration Statement will be declared effective
as of 4:30 p.m. Eastern time, on January 26, 2023, or at such other time as the Company or its outside counsel, McGuireWoods
LLP, may request via a telephone call to the staff of the Commission.

Once the Registration Statement
has been declared effective, please orally confirm that event with Rakesh Gopalan of McGuireWoods LLP at (704) 343-2275, or in his absence,
David Wolpa of McGuireWoods at (704) 343-2185.

Thank you for your assistance
in this matter.

    Very truly yours,

    /s/ Claude Maraoui

    Name:   Claude Maraoui

    Title:    President and Chief Executive Officer

cc:       Rakesh Gopalan, McGuireWoods LLP

SecProbe.io